Nancy A. Simonian

Insider Reports History

Entity
Individual
Location
C/O Syros Pharmaceuticals, Inc., 620 Memorial Drive, Cambridge, MA
Signature
/s/ Todd Rosenthal, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nancy A. Simonian:

Insider Reports Filed by Nancy A. Simonian

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SYRS Syros Pharmaceuticals, Inc. Dec 2, 2024 1 -$10K 4 Dec 4, 2024 Director
SYRS Syros Pharmaceuticals, Inc. Nov 25, 2024 1 -$35.7K 4 Nov 27, 2024 Director
SYRS Syros Pharmaceuticals, Inc. Oct 31, 2024 2 $0 4 Nov 4, 2024 Director
SYRS Syros Pharmaceuticals, Inc. Jun 5, 2024 2 $0 4 Jun 7, 2024 Director
SYRS Syros Pharmaceuticals, Inc. Mar 31, 2024 5 -$71.9K 4 Apr 2, 2024 Director
SGEN Seagen Inc. Dec 14, 2023 11 -$14.4M 4 Dec 15, 2023 Director
SYRS Syros Pharmaceuticals, Inc. Dec 1, 2023 5 $0 4 Dec 5, 2023 Director
SYRS Syros Pharmaceuticals, Inc. Oct 31, 2023 3 -$29.8K 4 Nov 2, 2023 President & CEO, Director
SGEN Seagen Inc. May 31, 2023 1 $0 4 Jun 2, 2023 Director
SYRS Syros Pharmaceuticals, Inc. Mar 31, 2023 3 -$4.78K 4 Apr 4, 2023 President & CEO, Director
SYRS Syros Pharmaceuticals, Inc. Feb 16, 2023 1 $0 4 Feb 21, 2023 President & CEO, Director
SGEN Seagen Inc. Dec 12, 2022 2 $321K 4 Dec 14, 2022 Director
SYRS Syros Pharmaceuticals, Inc. Oct 6, 2022 2 $0 4 Oct 11, 2022 President & CEO, Director
SGEN Seagen Inc. May 13, 2022 2 $0 4 May 17, 2022 Director
SYRS Syros Pharmaceuticals, Inc. Apr 1, 2022 1 -$65.9K 4 Apr 4, 2022 President & CEO, Director
SGEN Seagen Inc. Mar 2, 2022 2 $501K 4 Mar 4, 2022 Director
SYRS Syros Pharmaceuticals, Inc. Feb 15, 2022 3 $0 4 Feb 17, 2022 President & CEO, Director
SGEN Seagen Inc. May 14, 2021 2 $0 4 May 18, 2021 Director